Developing novel blood-stage malaria vaccines
<p>Natural exposure to Plasmodium falciparum’s asexual blood-stage results in protection against severe disease, but no vaccine using the widely-studied blood-stage antigens apical membrane antigen 1 (AMA1) or merozoite surface protein 1 (MSP1) has proven convincingly protective in clinical tr...
Autor principal: | Douglas, AD |
---|---|
Outros Autores: | Draper, SJ |
Formato: | Tese |
Idioma: | English |
Publicado em: |
2015
|
Assuntos: |
Registros relacionados
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
por: Kapulu, MC
Publicado em: (2014) -
Enhancing the efficacy of viral vector blood-stage malaria vaccines
por: Forbes, E
Publicado em: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
por: Elias, SC
Publicado em: (2014) -
Liver-stage vaccines for malaria
por: Longley, RJ
Publicado em: (2013) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
por: Bauza, K
Publicado em: (2012)